Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes

Background and Objectives Pasireotide decreases leak rates after pancreatic resection, though significant drug cost may be prohibitive. We conducted a cost‐effectiveness analysis to determine whether prophylactic pasireotide possesses a reasonable cost profile. Methods A cost‐effectiveness model com...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of surgical oncology 2016-06, Vol.113 (7), p.784-788
Hauptverfasser:	Abbott, Daniel E., Sutton, Jeffrey M., Jernigan, Peter L., Chang, Alex, Frye, Patrick, Shah, Shimul A., Schauer, Daniel P., Eckman, Mark H., Ahmad, Syed A., Sussman, Jeffrey J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Abscess - economics Abdominal Abscess - epidemiology Abdominal Abscess - etiology Abdominal Abscess - prevention & control Anastomotic Leak - economics Anastomotic Leak - epidemiology Anastomotic Leak - prevention & control Cost Savings Cost-Benefit Analysis cost-effectiveness Decision Trees Drug Administration Schedule Hormones - economics Hormones - therapeutic use Hospital Costs Humans Models, Economic Ohio Pancreatectomy pancreatic fistula Pancreatic Fistula - economics Pancreatic Fistula - epidemiology Pancreatic Fistula - etiology Pancreatic Fistula - prevention & control pancreatic leak pasireotide Postoperative Complications - economics Postoperative Complications - epidemiology Postoperative Complications - prevention & control Somatostatin - analogs & derivatives Somatostatin - economics Somatostatin - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!